Optimal plasma progranulin cutoff value for predicting null progranulin mutations in neurodegenerative diseases: A multicenter Italian study

Neurodegenerative Diseases

Volumn 9, Issue 3, 2012, Pages 121-127

  Ghidoni, Roberta ^a   Stoppani, Elena ^a   Rossi, Giacomina ^b   Piccoli, Elena ^b   Albertini, Valentina ^a   Paterlini, Anna ^a   Glionna, Michela ^a   Pegoiani, Eleonora ^a   Agnati, Luigi F ^c   Fenoglio, Chiara ^d   Scarpini, Elio ^d   Galimberti, Daniela ^d   Morbin, Michela ^b   Tagliavini, Fabrizio ^b   Binetti, Giuliano ^a   Benussi, Luisa ^a  

^a IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

^c IRCCS SAN CAMILLO HOSPITAL   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

Biomarker; Frontotemporal lobar degeneration; GRN; Neurodegeneration; Plasma cutoff; Translational research

Indexed keywords

PROGRANULIN;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MISSENSE MUTATION; NORMAL VALUE; NULL ALLELE; PRIORITY JOURNAL; PROGRANULIN BLOOD LEVEL; PROTEIN BLOOD LEVEL; SURVIVAL;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; FEMALE; HETEROZYGOTE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; ITALY; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; MUTATION; NEURODEGENERATIVE DISEASES; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 84858997674     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000333132     Document Type: Article

References (27)

1. Graff-Radford NR, Woodruff BK: Frontotemporal dementia. Semin Neurol 2007; 27: 48-57. (Pubitemid 46239039)
2. Sleegers K, Cruts M, Van Broeckhoven C: Molecular pathways of frontotemporal lobar degeneration. Annu Rev Neurosci 2010; 33: 71-88.
3. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF: Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51: 1546-1554.
4. The Lund and Manchester Groups: Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994; 57: 416-418.
5. Seelaar H, Rohrer JD, Pijnenburg YA, Fox NC, van Swieten JC: Clinical genetic and pathological heterogeneity of frontotemporal dementia: a review. J Neurol Neurosurg Psychiatry 2011; 82: 476-486.
6. Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, Snowden J, Adamson J, Sadovnick AD, Rollinson S, Cannon A, Dwosh E, Neary D, Melquist S, Richardson A, Dickson D, Berger Z, Eriksen J, Robinson T, Zehr C, Dickey CA, Crook R, McGowan E, Mann D, Boeve B, Feldman H, Hutton M: Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006; 442: 916-919. (Pubitemid 44285946)
7. Cruts M, Gijselinck I, van der Zee J, Engelborghs S, Wils H, Pirici D, Rademakers R, Vandenberghe R, Dermaut B, Martin JJ, van Duijn C, Peeters K, Sciot R, Santens P, De Pooter T, Mattheijssens M, Van den Broeck M, Cuijt I, Vennekens K, De Deyn PP, Kumar-Singh S, Van Broeckhoven C: Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 2006; 442: 920-924. (Pubitemid 44285947)
8. Benussi L, Ghidoni R, Binetti G: Progranulin mutations are a common cause of FTLD in Northern Italy. Alzheimer Dis Assoc Disord 2010; 24: 308-309.
9. Gijselinck I, Van Broeckhoven C, Cruts M: Granulin mutations associated with frontotemporal lobar degeneration and related disorders: an update. Hum Mutat 2008; 29: 1373-1386. (Pubitemid 352774891)
10. Chen-Plotkin AS, Martinez-Lage M, Sleiman PM, Hu W, Greene R, Wood EM, Bing S, Grossman M, Schellenberg GD, Hatanpaa KJ, Weiner MF, White CL 3rd, Brooks WS, Halliday GM, Kril JJ, Gearing M, Beach TG, Graff-Radford NR, Dickson DW, Rademakers R, Boeve BF, Pickering-Brown SM, Snowden J, van Swieten JC, Heutink P, Seelaar H, Murrell JR, Ghetti B, Spina S, Grafman J, Kaye JA, Woltjer RL, Mesulam M, Bigio E, Lladó A, Miller BL, Alzualde A, Moreno F, Rohrer JD, Mackenzie IR, Feldman HH, Hamilton RL, Cruts M, Engelborghs S, De Deyn PP, Van Broeckhoven C, Bird TD, Cairns NJ, Goate A, Frosch MP, Riederer PF, Bogdanovic N, Lee VM, Trojanowski JQ, Van Deerlin VM: Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration. Arch Neurol 2011; 68: 488-497.
11. van Swieten JC, Heutink P: Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia. Lancet Neurol 2008; 7: 965-974.
12. Ghidoni R, Benussi L, Glionna M, Franzoni M, Binetti G: Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration. Neurology 2008; 71: 1235-1239.
13. Finch N, Baker M, Crook R, Swanson K, Kuntz K, Surtees R, Bisceglio G, Rovelet-Lecrux A, Boeve B, Petersen RC, Dickson DW, Younkin SG, Deramecourt V, Crook J, Graff-Radford NR, Rademakers R: Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members. Brain 2009; 132: 583-591.
14. Litvan I, Agid Y, Goetz C, Jankovic J, Wenning GK, Brandel JP, Lai EC, Verny M, Ray-Chaudhuri K, McKee A, Jellinger K, Pearce RK, Bartko JJ: Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology 1997; 48: 119-125. (Pubitemid 27039529)
15. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH: Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996; 47: 1113-1124. (Pubitemid 26374873)
16. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimers disease: report of the NINCDS ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimers disease. Neurology 1984; 34: 939-944. (Pubitemid 14076461)
17. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303-308. (Pubitemid 29120227)
18. Benussi L, Binetti G, Sina E, Gigola L, Bettecken T, Meitinger T, Ghidoni R: A novel deletion in progranulin gene is associated with FTDP-17 and CBS. Neurobiol Aging 2008; 29: 427-435. (Pubitemid 351215590)
19. Benussi L, Ghidoni R, Pegoiani E, Moretti DV, Zanetti O, Binetti G: Progranulin Leu-271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide. Neurobiol Dis 2009; 33: 379-385.
20. Carecchio M, Fenoglio C, De Riz M, Guidi I, Comi C, Cortini F, Venturelli E,Restelli I, Cantoni C, Bresolin N, Monaco F, Scarpini E, Galimberti D: Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers: a case with atypical onset as clinical amnestic mild cognitive impairment converted to Alzheimers disease. J Neurol Sci 2009; 287: 291-293.
21. Coppola C, Rossi G, Barbarulo AM, Di Fede G, Foglia C, Piccoli E, Piscosquito G, Saracino D, Tagliavini F, Cotrufo R: A progranulin mutation associated with cortico-basal syndrome in an Italian family expressing different phenotypes of fronto-temporal lobar degeneration. Neurol Sci, E-pub ahead of print.
22. Marcon G, Rossi G, Giaccone G, Giovagnoli AR, Piccoli E, Zanini S, Geatti O, Toso V, Grisoli M, Tagliavini F: Variability of the clinical phenotype in an Italian family with dementia associated with an intronic deletion in the GRN gene. J Alzheimers Dis 2011; 26: 583-590.
23. Pietroboni AM, Fumagalli GG, Ghezzi L, Fenoglio C, Cortini F, Serpente M, Cantoni C, Rotondo E, Corti P, Carecchio M, Bassi M, Bresolin N, Galbiati D, Galimberti D, Scarpini E: Phenotypic heterogeneity of the GRN Asp22fs mutation in a large Italian kindred. J Alzheimers Dis 2011; 24: 253-259.
24. Rossi G, Piccoli E, Benussi L, Caso F, Redaelli V, Magnani G, Binetti G, Ghidoni R, Perani D, Giaccone G, Tagliavini F: A novel progranulin mutation causing frontotemporal lobar degeneration with heterogeneous phenotypic expression. J Alzheimers Dis 2011; 23: 7-12.
25. Sleegers K, Brouwers N, Van Damme P, Engelborghs S, Gijselinck I, van der Zee J, Peeters K, Mattheijssens M, Cruts M, Vandenberghe R, De Deyn PP, Robberecht W, Van Broeckhoven C: Serum biomarker for progranulin-associated frontotemporal lobar degeneration. Ann Neurol 2009; 65: 603-609.
26. Finch N, Carrasquillo MM, Baker M, Rutherford NJ, Coppola G, Dejesus-Hernandez M, Crook R, Hunter T, Ghidoni R, Benussi L, Crook J, Finger E, Hantanpaa KJ, Karydas AM, Sengdy P, Gonzalez J, Seeley WW, Johnson N, Beach TG, Mesulam M, Forloni G, Kertesz A, Knopman DS, Uitti R, White CL 3rd, Caselli R, Lippa C, Bigio EH, Wszolek ZK, Binetti G, Mackenzie IR, Miller BL, Boeve BF, Younkin SG, Dickson DW, Petersen RC, Graff-Radford NR, Geschwind DH, Rademakers R: TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. Neurology 2011; 76: 467-474.
27. Goldman JS, Rademakers R, Huey ED, Boxer AL, Mayeux R, Miller BL, Boeve BF: An algorithm for genetic testing of frontotemporal lobar degeneration. Neurology 2011; 76: 475-483.